1. The rationale and the early days {#s0005}
===================================

Growing up I was fascinated by the sea, and I always wanted to be a marine biologist engaged in research that would explore ocean life to the benefit of society. Following this childhood passion, I studied biology as an undergraduate and in 1974 I enrolled in an Oceanography MSc program, both at the Hebrew University of Jerusalem. At that time, we already knew that the world was headed for a major fishery crisis, as overfishing was rampant and marine/coastal pollution was adversely impacting the spawning grounds of many marine species. When it was time to choose my Master's thesis research topic, I decided to pursue marine aquaculture, which back then was in its infancy. The first bottleneck to be resolved in finfish aquaculture was the inability of many commercially important marine fish to reproduce reliably when raised in captivity. The budding mariculture industry had to rely on harvesting wild juvenile fish or broodstock, transporting them to the farming operation and growing them to harvest size (for juveniles) or stripping them to obtain eggs and sperm for the production of fertilized eggs, larvae and juveniles (for broodstock). These were, of course, very unreliable and unpredictable practices, as wild juveniles/broodstock were only available seasonally for a limited time, and in some years they could not be found at all. This led me (and several others in the field) to study fish reproductive biology and endocrinology, with the eventual goal of enabling predictable reproduction in captive fish and closing their life cycles. We hypothesized that fish do not reproduce in captivity because they do not experience the conditions of a spawning ground, and that the absence of these environmental conditions, which are difficult/impossible to simulate in captivity, causes a hormonal failure that is responsible for the lack of captive reproduction. The focus of the field during these early years (the 1970's and early '80's) was to study gametogenesis and develop assays for the hormones along the brain-pituitary-gonadal axis, so the entire brain-reproductive organization could be depicted. In 1974, I started my graduate research at the National Center for Mariculture in Eilat, Israel, joining the group that pioneered the development of aquaculture technologies for several important and already overfished marine fish. My initial model species was the gilthead seabream (*Sparus aurata*), a species that at the time was of major interest to the aquaculture industry in the Red Sea and Mediterranean regions.

In those days, seabream did not spawn at all in captivity. We started with the simple tools of histology and studied gametogenesis and reproductive cycles in this species. We found that while spermatogenesis is completed in captivity, ovaries develop to the final stages of vitellogenesis but do not undergo final oocyte maturation (FOM) and ovulation ([@b1045]). Instead, the vitellogenic oocytes undergo rapid atresia. While studying gonadal development in the seabream, we documented the fascinating process of sex reversal in this protandrous hermaphrodite ([@b1045], 1984). We also demonstrated that the seabream has an asynchronous ovarian development and thus is a batch spawner ([@b1045], [@b0230], [@b1055]). Both hermaphroditism and sequential spawning have important implications to broodstock management and egg production in the culture of this species ([@b1020], [@b0470]). In an effort to induce FOM, ovulation and spawning, we started to treat the females with the most effective hormonal spawning inducer at the time - human chorionic gonadotropin (hCG) (see for reviews [@b0180], [@b1060], [@b1075], [@b1065], [@b1050]). Using hCG certainly induced spawning ([@b0230]) and demonstrated that gilthead seabream undergoes daily cycles of FOM, ovulation and spawning that can last for up to 4 months ([@b1055]). However, very soon it became apparent that seabream broodstock would not respond to hCG if treated again in subsequent years. This lack of responsiveness was first hypothesized ([@b0365], [@b0180], [@b1040]), and later demonstrated ([@b1050]), to be due to an adaptive immune response with antibodies to the large hCG protein and thus the development of refractoriness to further hCG treatment.

The success of using pituitary extracts, hCG or other gonadotropins to induce spawning in captive fish, which was initiated by the pioneering work of Bernard [@b0285] and later implemented abundantly in a large number of species (see above reviews), indicated that in captivity the fish's own gonadotropin (LH) is not released from the pituitary, which is the reason for their failure to undergo FOM, ovulation and spawning. This was later conclusively demonstrated in a number of studies that measured pituitary and plasma levels of luteinizing hormone (LH) in fish raised in captivity and comparing them to fish sampled on their spawning grounds ([@b1065], [@b0480]; [Figure 1](#f0005){ref-type="fig"} ). This understanding, together with the discovery of the hypothalamic releasing hormones in mammals ([@b0010], [@b0065], [@b0430]), drove the fish reproductive biology community, including myself, to focus on basic and applied studies of fish gonadotropin hormone-releasing hormones (GnRHs) and the brain-reproductive axis. Very soon after the discovery of the luteinizing hormone-releasing hormone (LHRH), a few pioneers in our field used *in-vivo* and *in-vitro* approaches to demonstrate that fish brains possess gonadotropin-releasing potency and that synthetic GnRHs can stimulate gonadotropin release. Initial studies were conducted by the French INRA group of Bernard Breton, Roland Billard and Claudine Weil ([@b0045], [@b0040]) and were soon followed by a wonderful publication co-authored by three of the trailblazers in our field - Larry Crim, Dick Peter and Roland Billard ([@b0130]). The confirmation of GnRH activity in the fish brain led researchers and hatcheries to shift from gonadotropin-based spawning induction therapies to using GnRHs to stimulate the release of the fish's own LH from the pituitary and, in turn, ovulation and spawning (see for reviews [@b0180], [@b1065], [@b0135], [@b0615], [@b1050], [@b0475]). Additionally, being small decapeptides, GnRHs do not induce immune responses in the treated fish, thus allowing repeated treatments.Figure 1Yoni Zohar holds a live striped bass (*Morone saxatilis*) electro-fished on its spawning ground in the Chesapeake Bay before taking a blood sample for studying the level of hormonal failure that is responsible for the lack of FOM, ovulation and spawning in captive held fish. Maryland, USA, 1995

2. The glorious seventies - the birth of our family {#s0010}
===================================================

The seventies were exciting times to be in the field of fish reproductive biology. The growing interest in aquaculture and the focus on reproductive biology of farmed fish led to a surge of basic and applied research in the reproductive endocrinology of a number of species. This research covered every aspect of fish reproductive biology, from environmental control of gametogenesis to the study of the brain-pituitary-gonadal axis and the development of aquaculture applications. A wide range of approaches were utilized, with the exception of - hard to believe - molecular biology, which was not very advanced at the time. A milestone in the field was the inaugural International Symposium on Reproductive Physiology of Fish (ISRPF) in 1977 held in Paimpont, France and organized by the scientist who has been referred to by many of us as the grandfather of the field, Roland Billard. People were upbeat about the field and happy to be part of it. As a beginning PhD student attending his first international meeting, I was astonished to see my idols in the field imbibing freely, dancing on the tables and throwing pieces of baguette at each other. In this meeting, all the big names and pioneers in the field demonstrated its diversity and interdisciplinarity, which were already apparent back then. At the time, a debate was raging regarding the number of fish gonadotropins (GtHs), i.e., whether fish possessed one or two gonadotropins, if a "vitellogenic" GtH-I and "maturational" GtH-II existed and, if so, whether both of them (or only GtH-II) were glycoproteins? Elizabeth Burzawa-Gerard, Yves-Alain Fontaine, Bernard Breton, David Idler, John Sumpter and Madelaine Olivereau were arguing in Paimpont about the nature of fish gonadotropins. Dick Peter, Larry Crim, Pete Van-Oordt, Henk Goos, Maurice Dubois and Claudine Weil presented the early status of the fish GnRHs, their brain distribution and functions. Yoshi Nagahama, along with Bill Hoar, unveiled novel and exciting data on the cellular sources of gonadal steroids. Alexis Fostier, Bernard Jalabert and Zvi Yaron discussed the roles of steroids in gametogenesis and final oocyte maturation. Martin Schreibmann described the genetic control of fish maturation. Ed Donaldson and others proposed aquaculture applications of fish reproductive physiology and myself, totally intimidated by the grandeur of the event, made my first appearance in an international conference presenting my early basic and applied work on the gilthead seabream. This meeting, in my opinion, was the birth of a tight community of fish reproductive biologists who met every four years in different countries and continents. I was very lucky to attend all of the eleven Symposia on Reproductive Physiology of Fish and witnessed the growth and intensification of the field. I often wrote about and referred to the fact that fish became a prime vertebrate reproductive model, a model for primates and human reproduction (see more below) and that in my opinion our field was driven to such depth, breadth and excellence by the reproduction-related bottlenecks in aquaculture and the need to resolve them. But this viewpoint is in no way intended to undermine the exceptional group of scientists who have worked in the field, or their friendships and close collaborations, which I have experienced from the very early days of my career until the present day. In 1977, I started my PhD with the highly prolific, collaborative and integrated INRA team in France, where I was exposed to the passion, enthusiasm, creativity and friendship of these early days in our field, working with outstanding scientists such as Roland Billard, Bernard Breton, Alexis Fostier and Bernard Jalabert.

In 2014, I made some short opening remarks at the 9th ISRPF meeting in Faro, Portugal, organized by another pillar in the field, Adelino Canario. I reflected on why ISRPFs are the one meeting I have insisted on attending since 1977. The reason is that this community of fish reproductive biologists feels like a close family, which is not something you take for granted in science. I grew up in this community, learned from its distinguished members (including how to tie a necktie, which Martin Schreibmann and Dick Peter desperately and mostly unsuccessfully tried to teach me), collaborated and became friends with many of them, and have now grown to be one of its 'old guard'. Unfortunately, over the years our family has lost a few of its most influential members, among whom are Aubrey Gorbman, Howard Bern, Jimmy Dodd, Roland Billard, Dick Peter, Niall Bromage, and, a few weeks ago, Henk Goos (who succumbed to Covid-19). The rest of us will always fondly remember their scientific contributions, kindness, mentorship and friendship.

Obviously, since its inception at the 1977 Paimpont meeting, the newly formed family/community of reproductive physiologists has continued to grow and has welcomed many younger scientists, a good number of whom were "spawned" by the above-mentioned pioneers in the field (i.e., graduated from their labs).

3. From then onward {#s0015}
===================

**[The Gonadotropins]{.ul}:** The controversy about the number and nature of fish gonadotropins continued for over a decade until Hiroshi Kawauchi and his team clearly demonstrated that chum salmon has two glycoproteic gonadotropins, each consisting of two subunits, that are similar to FSH and LH in other vertebrates ([@b0335], [@b0885]). From that point on, we started to refer to fish gonadotropins, similar to other vertebrates, as FSH and LH. Interestingly (and somewhat ironically), these findings were first presented in 1987 at the 3^rd^ ISRPF in Newfoundland, Canada, the very ISRPF that was hosted by David Idler -- thus resolving the controversy surrounding his theory of non-traditional GtH-I and more traditional GtH-II ([@b0305], [@b0145], [@b0300], [@b0575]). To me, this important milestone was another strong testimonial to the collaborative nature of the family. From then on, led by young (and now young in spirit) stars like Penny Swanson, Sylvie Dufour, Abigail Elizur and Berta Sivan, several groups purified and characterized fish FSH and LH and cloned their genes, a process that was rapidly applied to multiple fish species once PCR amplification technology was implemented ([@b0195]), negating the need for the collection of thousands of pituitaries for the synthesis and screening of the traditional cDNA libraries. This progress, together with the production of recombinant LH and FSH hormones, paved the way for studying the GtHs' respective functions, evolution, annual and daily patterns, receptors, structure-function, mechanisms of action, and regulation of their synthesis and secretion at the hormonal and molecular levels ([@b0190], [@b0260], [@b0380], [@b0680], [@b0790], [@b0160], [@b0795]). *In vivo* and *in vitro* studies demonstrated the importance of FSH in the control of earlier stages of gametogenesis, spermatogenesis in males, and oogenesis in females. LH was implicated in the regulation of the final stages of gametogenesis, FOM and ovulation in the female and spermiation in the males (see above reviews). As mentioned earlier, it is LH that is not released from the pituitary in broodstock of many commercially important fish held in captivity, which is the reason for their failure to spawn. Although, as explained in section 1 above and section 4 below, the field of spawning induction has moved from the use of gonadotropins to the use of GnRHs, advances in the domain of gonadotropin biotechnology, primarily the work of Ana Gomez ([@b0440], [@b0435], [@b0600]) and Abigail Elizur ([@b0595]), opened new avenues to using FSH and LH plasmids, somatic FSH/LH gene transfer and recombinant FSH and LH therapies for inducing gametogenesis in farmed fish.

**[The gonads]{.ul}**: Moving down from the pituitary to the gonads, I have watched the field make a huge leap since we started by exploring the effects of simple estrogens and androgens on fish reproduction. As long ago as the early sixties, David Idler's group (which initially worked on steroids before moving to gonadotropins) found that fish gonads produce interesting and unique C21 steroids, specifically the progestin 17α,20 β-dihydroxy-4 pregnen-3-one (17 α,20 β-P; now referred to as 17,20 β-dihydroxypregn-4-en-3-one) that was identified in the plasma of sockeye salmon during the preovulatory period ([@b0310]). Then came the exciting seventies when a number of young and creative scientists - Bernard Jalabert, Alexis Fostier, Yoshi Nagahama, Peter Thomas, Rick Goetz and others - demonstrated, using *in vivo* and *in vitro* studies, the critical role of the 17α,20 β-P in inducing final oocyte maturation in several fish species. This activity of 17α,20 β-P, which seems to be quite ubiquitous in a wide range of fish species (see reviews by [@b0710], [@b0215], [@b0225], [@b0705], [@b1065]) led this steroid to be referred to as the maturation inducing steroid (MIS). In subsequent years, using advanced steroid biochemistry approaches, Sandy Scott, his former PhD student, Adelino Canario, David Kime, Rudiger Schultz and other labs discovered the large diversity of steroids produced by fish gonads, including additional C21 steroids that are also produced at the time of final oocyte maturation (above reviews; [@b0715], [@b0695]). In 2010, we read the inspiring review written by a trio of the field's leaders - Sandy Scott, John Sumpter and Norman Stacey, discussing the evidence that 17α,20β-P was not only a 'female steroid', but also a major 'male steroid' involved in the initiation of meiosis during spermiation ([@b0710]). And although John Sumpter started as one of us in the 1977 Paimpont meeting, he transitioned soon thereafter to a greater and higher universe, following his breakthrough discovery that river and lake waters contain estrogenic endocrine disrupters that induce vitellogenin production in the male fish inhabiting these habitats ([@b0780]). We dearly missed John's British sense of humor but fortunately enough he later returned to our community and meetings. Since then, this field has seen additional major contributions towards understanding the reproductive, hormonal and genetic impacts of environmental endocrine disrupting chemicals from John and his former PhD student, Charlie Tyler, as well as from Peter Thomas, Oliana Carnevali, Glen Van Der Kraak and Olivier Kah ([@b0050], [@b0055], [@b0075], [@b0735], [@b0850], [@b0845]).

Also, around the late seventies to the early eighties, we saw the emergence of the "two-cell type" model of steroidogenesis in fish. Led by one of our field's luminaries, Yoshi Nagahama, classic experiments in salmonids and other fish species showed that both estradiol-17β, the steroid responsible for oocyte growth and vitellogenesis, and the MIS (17α,20β-P) are produced in two steps, with each step occurring in a different follicular cell layer. During oocyte growth, the theca cells produce testosterone that is aromatized to estradiol-17β in the granulosa cells. When fully grown vitellogenic follicles are ready to enter FOM, there is a shift in steroidogenesis, such that theca cells start to produce 17α-hydroxyprogesterone that is converted to 17α,20β-P in the granulosa cells. Detailed *in vitro* and *in vivo* studies by Yoshi and his early students - Graham Young, Hirohiko Kagawa, Shinji Adachi, Hideki Tanaka and others -, integrated hormonal, biochemical, molecular and functional approaches to demonstrate the details of the drastic and very fast enzymatic changes occurring in the follicular cells during this transition (see reviews by [@b0660], [@b0840], [@b0590], [@b0535], [@b0355], [@b0525], [@b0530], [@b0550], [@b0545], [@b0540]). Yoshi has been a pillar in our field, we have always eagerly waited to listen to his inspirational talks, he has been highly collaborative and a real friend and welcomed everyone to his lab (although they had to work long shifts!); a real sensei in our field.

Another example of the concept of "fish as an endocrine vertebrate model" came from Peter Thomas's innovative work in fish showing, for the first time in any vertebrate, that gonadal steroids can drive rapid actions initiated at the cell surface membrane receptors (as opposed to the nuclear receptors), which circumvent the relatively slow classic gene-mediated mechanism of steroid hormone action. This novel mechanism is non-genomic and involves rapid activation of intracellular signal transduction pathways within only a few minutes (see for review [@b0830], [@b0825]). Peter and his colleagues presented evidence demonstrating cross-talk between the traditional, genomic slow-acting pathway and the alternative, cell membrane-mediated, non-genomic hormonal pathway during the above-described fast transition in fish ovaries from estradiol-17β to 17α,20β-P production towards the end of oogenesis, regulating the onset of oocyte maturation. These findings had major fundamental implications, not only to the field of comparative endocrinology but also to the biomedical sciences such as in the field of cancer. As Peter was once quoted saying "Fish are excellent models for examining many aspects of vertebrate physiology because the results can often be translated to humans and impact biomedical research. For example, we found that the huge numbers of eggs in fish ovaries provide an abundant source of tissue for purifying steroid membrane receptors on vertebrate eggs. In addition, the characteristics of the fish and human steroid membrane receptors are very similar".

**[Reproductive pheromones]{.ul}** [:]{.ul} Back to the MIS - several of those who worked at the time on these steroids wondered why they display such high levels in the fish circulation in some species (e.g., salmonids) but not in others (e.g., sparids), after all they are produced and act at the gonad. At the same time, intense steroid reduction and glucuronide and sulfate conjugation processes were discovered, rendering the MIS and other sex steroids present in plasma hydrophilic. These polar and conjugated steroids are excreted to the water mainly through fish urine, while free steroids are preferentially released through the gills ([@b0890]). Taken together, these observations led to the hypothesis that these key gonadal steroids may end up in the water (in conjugated or free form) and act as pheromones that facilitate successful reproduction and spawning ([@b0770], [@b0705], [@b0700]). A series of very elegant studies ensued, totally unique to fish, confirming this hypothesis. Norman Stacey, and his former student Peter Sorensen, Sandy Scott, Adelino Canario, Makito Kobayashi, Lorenzo Colombo and others, integrated platforms of fish behavior, olfaction and electrophysiology, endocrine assays and gonad biology, to clearly demonstrate that several male and female gonadal steroids indeed act as pheromonal cues to elicit final hormonal and gametogenic changes in their counterpart gender, as well as attract each other to engage in spawning behavior. Moreover, the same researchers demonstrated that pheromones and their olfactory ability are species-specific, generally males and females of one species respond only to conspecific individuals and will ignore heterospecific pheromones. This explains how in the wild, different species of fish can reproduce at the same time while keeping their mating conspecific. This fascinating field of reproductive biology, very unique to fish, has been abundantly reviewed over the years ([@b0740], [@b0765], 2009; [@b0760], [@b0755], [@b0345], [@b0340], [@b0455]). Looking at the authorship lists of publications in this field once again is a testimony to the close collaborations between scientists working in our field. The competitive rivalries so common in the life sciences simply did not exist in our fish reproductive physiology family.

**[Gonadal feedback to the brain-pituitary axis]{.ul}**: One of the early papers authored by Roland Billard used gonadectomy to demonstrate, for the first time in fish, gonadal feedback on pituitary gonadotropin secretion ([@b0030]). In collaboration with Dick Peter, the two pioneers showed that this gonadal feedback is exerted by sex steroids ([@b0025]). The crosstalk between the gonads and the brain-pituitary axis has since been studied in detail by many labs and in multiple fish species. Researchers like Vance Trudeau and Gustavo Somoza, who graduated from Dick Peter's lab ([@b0855], [@b0865]) and Olivier Kah ([@b0330], [@b0165]) integrated the study of hormones, receptors and their genes with high resolution microscopy to dissect the details of the feedback dialog between the gonads, the brain and the pituitary, at the level of the GnRHs, GtHs, other neurohormones and their receptors involved in the control reproduction. Olivier and his former post-doc, Jose-Antonio Munoz-Cueto, took the field to the next level via their outstanding imaging and mapping of the brain and pituitary sites involved in these communications, as well as other endocrine factors involved in this axis. To this end, I am very proud that the three of us (along with Carmen Sarasquete) joined forces in the early 2000's to publish a detailed atlas of the brain of the commercially important gilthead seabream (*Sparus aurata*) ([@b0465]).

**[Sex determination and differentiation]{.ul}**: The large diversity of fish species represents a wide range of gonadal developmental patterns and physiologies. While most fish are gonochoristic, many are hermaphroditic with protandrous, protogynous and even simultaneous patterns of bisexual gonadal development. As I mentioned above, hermaphroditism in fish captured my interest from my early days, and over the years, as my group occasionally pursued social and endocrine mechanisms involved in sex reversal (e.g., [@b0945], [@b0665]), I witnessed the excellent work of Ching Fong Chang, whose group significantly contributed to our understanding of endocrine, molecular and epigenetic processes regulating sex reversal in fish (e.g., [@b0960], [@b0955], [@b0950], [@b0390]).

Also, fish display a variety of mechanisms of gender determination, ranging from genetic to environmental, with homogametic males or females (see review by [@b0605]). Fundamental biology and aquaculture interests drove intensive research into the mechanisms and processes controlling sex determination and differentiation in fish. Again, starting in the seventies, several groups from around the world began describing the intricate network of hormones and other factors, both brain and gonadal, that interact to determine gender in a large number of fish. Early studies from one of our field's founders, Edward Donaldson ([@b0175], [@b0185], [@b0290]), and his former student, Francesc Pifferer ([@b0630]), combined the basic and translational aspects of this topic. Working in parallel on the same species but on two separate continents, Yoshi Nagahama and Manfred Schartl and their groups conducted thorough and very elegant studies that revealed and characterized the first sex determining genes in a fish, the medaka ([@b0570], [@b0425] reviewed by [@b0360]). Yoshi Nagahama and his many colleagues went on to dissect and elucidate the ensuing sex differentiation cascade that determines the gender of fish ([@b0155], [@b0520], [@b1000], [@b0565], [@b0355], [@b0095], [@b0090], [@b0560]).

**[Monosex and sterility:]{.ul}** With the growth and intensification of aquaculture, it became apparent that quite often one gender performs better than the other, reaches sexual maturity at a different age, and that achieving sexual maturity is associated with reduced growth rate, deterioration of flesh quality and in some species, mortality. This led to a growing interest in producing monosex populations or reproductively sterile fish, thereby overcoming these hurdles. The urgency of producing reproductively sterile fish significantly increased with the recognition that aquaculture may cause "biological pollution" in the environment via farmed escapees interbreeding and displacing wild fish stocks. Sterile fish will provide a means to biologically/genetically contain farmed fish, in addition to resulting in better performance. Starting with steroid treatments combined with hybridization to induce sex reversal and sterility in cichlids, cyprinids and salmonids, the field very quickly moved to chromosome set-manipulations, gynogenesis and polyploidy. During the late seventies and into the eighties, we saw the emergence of studies and technologies whereby eggs are activated to start development by sperm in which the genetic content has been destroyed, thus resulting in animals possessing only maternal inheritance (gynogenesis). In this process, shortly after activation the eggs are exposed to environmental shock (pressure or temperature) that leads to diploidization of the embryos, generating all-female offspring. Using intact sperm to fertilize the eggs prior to shocking them results in triploid individuals, which are often sterile. This technical breakthrough, together with androgenesis (to produce all-male diploids in fish with homogametic males) and sex-reversing homogametic individuals to obtain broodstock of the opposite phenotypic sex, led to aquaculture applications generating monosex or sterile fish (see for reviews [@b0110], [@b0835], [@b0170], [@b0205], [@b0020]). Optimizing polyploidy technologies (e.g., [@b0730]) led to scaling up and commercializing genotypically all-female triploids, phenotypically sterile fish for a number of species. The booming Atlantic salmon industry, which has been blamed for significant biological pollution ([@b0220]), started to introduce sterile triploid fish into floating net-pens, mainly in Norway and Scotland. However, very quickly it became apparent that triploid fish may under-perform their diploid counterparts. For instance, in suboptimal conditions they may display morphological deformities, cataract symptoms ([@b0820], [@b0815]) and possibly compromised immune systems and increased susceptibility to disease ([@b0020]).

Potential obstacles with scaling up the triploidy technology drove a search for alternative approaches to produce reproductively sterile fish. Many of us in the field brainstormed possible strategies to induce sterility and, I am proud to say, an excellent former PhD student of mine (they were all outstanding!), Ten-Tsao Wong, was one of the first to explore a very promising approach - eliminating primordial germ cells (PGCs) during early development (see for reviews [@b0930], [@b0925]). In fish, PGCs become established immediately after fertilization and undergo guided migration to their final destination in the gonads during a short window of time very early in development ([@b0035], [@b0905], [@b0275]). The hypothesis was that if the PGCs are prevented from making it to the gonads, the fish will become sterile. Indeed, using transgenic approaches to alter the signaling pathways involved in the PGC migration ultimately led to sterility ([@b0350], [@b0940]). In a series of inspiring studies, a young star in our field, Anna Wargelius, used gene editing to knockout one of the key genes involved in the development of PGCs - the deadend gene (*dnd*) ([@b0905]) in Atlantic salmon. The mutated fish had no germ cells in the gonad, were 100% sterile, and performed as well as the wild-type salmon ([@b0900], [@b0895]). However, with the uncertainty about authorizing the use of gene-edited fish in aquaculture, the implementation of this approach in the industry is still remote.

In the meantime, Ten-Tsao Wong and I worked on an alternative technology for sterility that avoids genetic modifications. Our concept is to use transitional knockdown gene-silencing (morpholino) to prevent the production of the dnd protein during the short window of time of PGC migration in early development. Also, with the objective of making this technology scalable, we set out to immerse fish eggs, before or after fertilization, in the gene silencing agent (dnd morpholino) together with endocytosis-enhancing factors to boost uptake of the morpholino into the eggs. We started with the zebrafish model. Indeed, a 5-hour immersion of zebrafish eggs in these compounds disrupted the migration of PGCs and led to 100% sterility with no germ cells in the gonads ([@b0935], [@b0925]). Since then, we have been engaged in collaborative efforts with industry, as well as academic colleagues, to implement and optimize this strategy primarily in Atlantic salmon and rainbow trout, with increased confidence of imminent success. At the same time, we have been testing this strategy in other farmed species such as tilapia, sablefish and kingfish. The history of the effort to develop sterile fish is another example of the close synergism between basic and translational research in our field of fish reproductive biology.

**[Puberty:]{.ul}** Another approach to control the age-at-first maturity in farmed fish is through the manipulation of puberty. The idea is to be able to advance the onset of puberty in potential broodstock of species that reach late sexual maturity (sturgeon, striped bass), and delay pubertal onset in species that reach sexual maturity before harvest (gilthead seabream, salmon and many others). Two of our community's most prolific members, Manuel Carrillo and Silvia Zanuy (whose recent retirements have left a huge void in the ISRPF community), made major contributions to the understanding of environmental and hormonal control of puberty, focusing on the commercially important European seabass (reviewed by [@b0085], 2015). Parallel studies were performed in other farmed fish and all the main contributors to this field, from eight institutions and four countries, joined forces in publishing several seminal reviews on the control of puberty in farmed fish ([@b0810], [@b0015], [@b0125]) - again reflecting the strong spirit of collaboration in our field. As explained in these reviews, simple environmental manipulations have already been implemented by the industry, such as adding lights to prolong days and delay puberty in large scale net-pen production of Atlantic salmon and Atlantic cod. One of the major contributors to this field was Niall Bromage (e.g., [@b0060], [@b0255]), a friend, a collaborator and a teacher who was taken from our community much too early. More recently, and since the discovery that brain kisspeptins also play a role in regulating puberty in fish (reviewed [@b1015], [@b0080]), studies which involved collaborations between Abigail Elizur, Berta Sivan and my group used sustained administration of kisspeptins to advance puberty in the commercially important yellowtail kingfish ([@b0580]).

4. GnRHs - the basic and the applied {#s0020}
====================================

As mentioned in section 1 above, the discovery of brain GnRH, together with the recognition that the lack of FOM, ovulation and spawning in farmed fish is a result of a failure of LH release from the pituitary, prompted the field to focus on studying the fish GnRHs and using them to induce LH release and in turn oocyte maturation, ovulation and spawning. Many excellent reviews were written on both basic ([@b0325], [@b1015]; Munoz-Cueto et al., 2020; [@b0675], [@b0670], [@b0315], [@b0865]) and applied ([@b1075], [@b1065], [@b0965], [@b1050], [@b0495], [@b0490], [@b0410]) aspects of this research. Therefore, herein I will simply review the general evolution of the field and some milestones.

**[From discovery to the industry]{.ul}** [:]{.ul} A major breakthrough in the field was the discovery in 1983 of the first fish GnRH by Nancy Sherwood and colleagues ([@b0720]). This decapeptide was first isolated from brains of chum salmon and was therefore named salmon (s) GnRH. The same sGnRH was then found in a few additional fish species. At the same time, several groups began to use mammalian LHRH or sGnRH to induce LH release, ovulation and spawning in a number of farmed species. Very soon, it became apparent that although the GnRHs indeed induced pituitary LH release, the duration of the blood LH surge was very short and a single GnRH injection was not sufficient to induce FOM and ovulation ([@b0655], [@b0140], [@b1065], [@b1030]). Our group then showed that this short-lived action of the native GnRHs was the result of quick degradation, and thus inactivation, of the administered native GnRHs by specific peptidases that cleave the decapeptide between positions 5-6 and 9-10 ([@b1025]). Substituting amino acids in positions 6 and 10 of the peptide led to the production of synthetic GnRH analogues (GnRHa), which were shown to be resistant to enzymatic degradation ([@b0235], [@b0915], [@b0910]). These cleavage-resistant GnRHa displayed higher affinity to the pituitary GnRH receptors ([@b0150], [@b0265], [@b0585]) and induced a much stronger LH release from the pituitary, in terms of both amplitude and duration of the LH surge ([@b0620], [@b1075], [@b1065], [@b1030], [@b0135]). However, although at a slower rate than the native peptides, even these "super-potent" GnRHa were still cleared relatively rapidly from the fish circulation ([@b0240]), probably due to the fact that being short peptides they were processed and excreted by the fish as intact molecules. In some fish species, a single injection of super-potent GnRHa was sufficient to induce FOM, ovulation and spawning. However, in others, especially in serial/batch spawners, such as our seabream and European seabass models, a single GnRHa injection was not sufficient and multiple injections of GnRHa were required. The repeated injections and handling were labor intensive and stressful to the fish, often leading to mortalities.

To overcome this shortcoming, Larry Crim, Dick Peter, Nancy Sherwood and my lab all searched for ways to prolong the presence of GnRHa analogues in the fish circulation. To achieve that goal, we experimented with the use of polymer-based, controlled-release delivery systems that provided a sustained presence of GnRHa in the blood and a prolonged release of LH from the pituitary, which in turn successfully induced FOM, ovulation and spawning. I started by treating female seabream with commercially available GnRHa implants that were used to down-regulate gonadotropin release in humans with hormonally-dependent cancers, such as breast or prostate cancer. The fact that, in fish, prolonged presence of GnRHa induced continuous release of LH rather than downregulating it, was surprising and scientifically very intriguing to many of us, but also enabled us to use this strategy to induce spawning in captive broodstocks. To be able to develop our own, fish-specific GnRHa delivery systems, I joined for one year (1988) the MIT lab of the guru of controlled-release technology Robert Langer (see for example [@b0370]). While at MIT, I developed several GnRHa polymeric delivery systems and worked with commercial hatcheries in Maine to test their potency in synchronizing ovulation in Atlantic salmon ([Figure 2](#f0010){ref-type="fig"} ). A variety of polymers and delivery systems (implants and microspheres) have since been used to enable optimal patterns of GnRHa/LH release, in most cases tailored to the ovarian physiology of the fish of interest (i.e., one-time spawner, batch spawner, etc.). This resulted in a generic GnRHa-based spawning induction technology, which has been successfully tested and optimized in a wide range of aquaculture species and abundantly implemented in the industry over the years (see reviews listed above, [Figure 3](#f0015){ref-type="fig"} ). The GnRHa controlled release delivery systems were found to be highly effective in solving another broodstock problem in aquaculture - the insufficiency of sperm production in males ([@b1050], [@b0485], [@b0515]). The technology proved to be very efficient in enhancing sperm production in captive male broodstock, also enabling the use of fewer males for the spawning operations and thereby saving space, labor and money. The person who conducted many of the studies and contributed the most to the development, optimization, testing and industrial implementation of the GnRHa controlled-release technology was Constantinos (Dinos) Mylonas, who started the work as my brilliant PhD student and later flourished as an independent and highly productive scientist (e.g., [@b1050], [@b0505], [@b0510], [@b0495], [@b0490], [@b0475], 2017).[Fig 4.](#f0020){ref-type="fig"} Figure 2Yoni Zohar strip-spawns an Atlantic salmon which was induced to ovulate using GnRHa implant. Maine, USA, 1988Figure 3Yoni Zohar administers GnRHa implants to Atlantic salmon held in floating net-pens in a commercial broodstock operation in Chile, 1993.Figure 4Yoni Zohar standing by a broodstock gilthead seabream tank at the Aquaculture Research Center, Institute of Marine and Environmental Technology, University of Maryland. 2019.

Although the use of the GnRHa alone (injections or delivery systems) efficiently induced ovulation, spermiation and spawning in many farmed species, in some other species GnRHa alone is not enough. In the 1977 Paimpont 1^st^ ISFRP meeting, a very productive collaboration between Dick Peter, Larry Crim and Henk Goos provided the first evidence for the existence of a gonadotropin release inhibitory factor (GRIF) in the brain of goldfish ([@b0610], [@b0625]). Many follow-up studies led by Dick Peter, his past graduate students John Chang and Hamid Habibi, as well as Olivier Kah, Sylvie Dufour and others, have identified GRIF as dopamine, which was later confirmed in all studied cyprinid fish and a handful of other fish species (reviewed by [@b0190]). As presented by Dick Peter, Hao-Ren Lin and Glen Van Der Kraak at the 3^rd^ ISRPF in 1987, in broodstock of such fish, LH release, FOM, ovulation and spawning can only be induced by the administration of both GnRHa and dopamine antagonists ([@b0620]). More recently, we found out that the situation is more complex (which is not surprising), as other inhibitory factors have been shown to be involved in modulating pituitary gonadotropin release, primarily the gonadotropin inhibitory hormone - GnIH (e.g., [@b0640], [@b0745]). It still remains to be seen if this discovery will have practical implications related to the control of reproduction in farmed fish.

**[The biotechnological approach:]{.ul}** As the GnRH spawning induction technology became widespread, more and more groups applied it to additional fish species. One fish of special interest is the bluefin tuna (BFT), for which closing the life cycle became a priority in the development of its aquaculture, especially in light of dwindling BFT abundance in the oceans. Indeed, our GnRHa sustained release technology has been optimized and successfully used for induction of BFT spawning ([@b0500], [@b0685]) and has since been implemented in the industry ([@b1010]). However, keeping the giant bluefin tuna broodstock in captivity is not a trivial task. This quandary drove one of the brightest minds in our field, Goro Yoshizaki, to originate the idea of germ cell transplantation and surrogate broodstock technology. In 2002, Baltimore (where I have been working for the last 30 years) hosted the annual meeting of the Society for the Study of Reproduction and I was asked to co-organize a session dedicated to fish reproduction. When we reviewed submitted abstracts, I was mystified and intrigued by one submission that described manipulating fish primordial germ cells (PGCs) so they could be visualized for harvesting from one fish species (donor) and transplanted into another (recipient). This is how I met Goro Yoshizaki, which led to a wonderful decades-long friendship.

Goro's rationale was totally out-of-the-box - yet very simple. If it is so difficult to maintain and spawn bluefin tuna (which we all know is of huge importance in Japan) in captivity, why not transfer PGC of bluefin tuna to a much smaller closely related surrogate, such as mackerel, and generate mackerel broodstock that produce tuna gametes and offspring? Sounds like science-fiction? Well, for the past 20 years Goro and his colleagues have worked diligently to make this concept a reality. Starting with salmonids, they were indeed able to microinject rainbow trout PGCs into masu salmon. The transplanted PGCs colonized the gonads of the recipient masu salmon and differentiated into functional eggs and sperm, which led to the production of trout offspring from salmon ([@b0805]). In follow-up studies, Goro demonstrated the extraordinary plasticity in fish gamete differentiation, as both oogonia and spermatogonia transplanted into surrogate fish were able to develop into either mature eggs or sperm in the recipient fish, and were successfully used to generate offspring ([@b0650], [@b0970], [@b0375]). His group later implemented the surrogate broodstock technology in a number of other commercially important fish, such as yellowtail ([@b0450]) and the Japanese fugu (Tiger puffer, [@b0270]). Goro also used the germ cell transplantation concept to generate reproductively sterile fish ([@b0555]). For more details on his groundbreaking basic and translational work, the readers are referred to recent reviews by [@b0975], [@b0980]. A couple of years ago, I visited Goro's lab in Tokyo and saw juvenile surrogate mackerel carrying bluefin tuna germ cells. In March 2020, Goro wrote to me that although recipient male mackerel produced functional tuna sperm, the effort is still underway for the females. Stay tuned, everyone!

**[Back to the GnRH bench:]{.ul}** The success in resolving the spawning bottleneck in aquaculture led us all back to the bench, trying to better understand why the endogenous GnRH 'malfunctions' in the captive broodstock of many species. While I cannot say that we have answered that question, we have certainly learned a great deal about the very unique fish GnRH system (reviewed by [@b0325], [@b0320], [@b1015], [@b0100], [@b0105], [@b0315]; Munoz-Cueto et al., 2020). Following the above-mentioned discovery of sGnRH in salmonids and many other species of fish, a second form of GnRH was found to be present in fish brains, the ubiquitous chicken (c) GnRH-II (as it was referred to at the time) ([@b0005]). Around the same time, my group collaborated with Nancy Sherwood trying to identify the nature of the GnRHs present in the gilthead seabream. To achieve this goal, we collected 10,000 (!) seabream brains and pituitaries and very carefully shipped them on dry ice to Nancy's lab, where her team used HPLC combined with GnRH immunoreactivity and amino acid analysis to characterize the seabream GnRHs. A couple of months later Nancy informed me that something must have gone wrong during the collection and/or shipment of the brains and pituitaries. She had detected 3 GnRH peaks in the HPLC chromatogram (we expected only two, sGnRH and cGnRH-II), which she thought may have indicated that the GnRHs had degraded to smaller, yet still immunoreactive, fragments. A bit frustrated, but still determined, we went back to the fish farm and collected and shipped another 5,000 brains and pituitaries to Nancy, who again saw the same three peaks. It then dawned on us that we had just discovered, for the first time in any vertebrate, that the seabream brain possesses three forms of GnRH and, adding to the excitement, that one of the three forms was a novel GnRH isoform that we named seabream (sb) GnRH ([@b0635]). The other two forms were the previously known sGnRH and cGnRH-II. Using molecular approaches, we then confirmed the presence of three GnRHs via the isolation and characterization of three corresponding cDNAs in the seabream brain ([@b0250], [@b0245], [@b0115]). Several very exciting years in the GnRH field ensued, where more and more species of fish, mostly more-evolved fish such as many of the perciforms, were shown to possess three forms of GnRH. This indicated that our 3-GnRH discovery in seabream, which was initially thought to be the exception, had suddenly become the rule. In an effort to understand the functional significance of GnRH multiplicity and the roles of each of the isoforms, our lab and others mapped the sites of expression of the three GnRHs in the brain, tracked their projection to the pituitary, and studied their biological activities and affinities to GnRH receptors. In addition, we monitored levels of the three GnRHs and their mRNAs in the brain and pituitaries of several species (e.g. [@b0245], [@b0280] and above reviews). All of these studies demonstrated that in fish with three GnRHs, the novel GnRH (sbGnRH in our case) is the hypophysiotropic form that is most relevant to gonadotropin release and gametogenesis. Most of the less-evolved fish species (e.g., salmonids and cyprinids), however, possess only two forms of GnRH and, in these species, sGnRH (the first fish GnRH discovered) is the hypophysiotropic peptide.

During the nineties, the field also witnessed the discovery of several additional forms of GnRH, specifically in fish possessing three GnRHs, where a species-specific form is usually the hypophysiotropic one. With the increasing number of GnRH variants discovered, and in order to standardize GnRH nomenclature and avoid confusion, a new classification of the GnRH forms was adopted based on the phylogenetic analysis of known sequences and their respective sites of expression ([@b0210], [@b0325], [@b1015]; Munoz-Cueto et al, 2020). According to this new nomenclature, the three GnRHs are now referred to as GnRH1, 2 and 3. In all fish, GnRH2 is the ubiquitous cGnRH-II. In fish with three GnRHs, GnRH1 is the form that expresses in the preoptic area (POA) of the brain and whose neurons project to the pituitary (ergo, the hypophysiotropic GnRH). GnRH3 is the form that, in fish with 3 GnRHs, expresses in the olfactory bulb and terminal nerve (OB/TN) areas of the brain. In all fish, regardless of the number of GnRHs, GnRH2 expresses in the midbrain tegmentum and projects to several brain areas. Fish with two GnRHs do not possess GnRH1, and subsequently GnRH3 is expressed in both the OB/TN, ventral telencephalon and the POA, and projects to the pituitary. It is thus considered to be the hypophysiotropic GnRH in these species. While this nomenclature is still somewhat confusing, it has become the standard in the field.

Whereas the hypophysiotropic GnRH has been clearly identified in many fish, the field is still trying to understand the exact roles of the non-hypophysiotropic GnRHs (either one or two forms depending on the species). Accumulating evidence indicates that GnRH2 is involved in integrating reproduction with feeding activities, and possibly also in reproductive behavior and in transducing photoperiod information processed by the pineal gland into circadian reproductive events (reviewed by Munoz-Cueto, 2020). The OB/TN GnRH3 has been implicated in transducing external cues, such as olfaction and social information (pheromones) to reproductive processes ([@b0875]; Munoz-Cueto 2020). Additionally, the multiplicity of GnRHs across fish and vertebrate species has raised many interesting evolutionary questions that were addressed by several excellent reviews ([@b0645], [@b0325], [@b0675], [@b0670], [@b0405], [@b0105], [@b0880], [@b0190], [@b0315]; Munoz-Cueto et al., 2020; [@b0865]).

The story of GnRH multiplicity is another striking example of the concept of "fish as a vertebrate/primate model". For years after the discovery of the LHRH in humans, it was believed that humans possess only one form of GnRH. However, the widespread demonstration of GnRH multiplicity in fish (and other non-mammalian vertebrates) led the neuroendocrine research community to re-visit the mammalian GnRH situation and, indeed, to discover two GnRH isoforms in the brains of primates - the initially-described LHRH (GnRH1) and the ubiquitous GnRH2.

**[And then came the small fish models]{.ul}:** During the mid-nineties, when most of the major discoveries on GnRH multiplicity were made, we witnessed the emergence of the small fish models - zebrafish and medaka. Interestingly, zebrafish possess 2 GnRH isoforms while the medaka has 3 GnRHs, thus allowing comparative studies between these two GnRH system models. The fact that these fish reach sexual maturity within 3 months, together with the availability of a range of applicable genomics/post-genomics platforms such as full genome sequencing, gene transfer, fluorescence labeling, gene silencing, gene editing and others, enabled many of us in the field to reach new levels of understanding of the GnRH and HPG axis. Using transgenic fish expressing fluorescent proteins (driven by the 2/3 GnRH promotors) in the GnRH neurons enabled detailed mapping of the GnRH system and its early development. Knockdown and ablation technologies led to progress in deciphering the functions of the 2/3 GnRHs and the regulation of their development, expression and activities. This progress has been abundantly reviewed (see above reviews). It is also interesting that, following the confirmation that the zebrafish possesses only 2 forms of GnRH ([@b0775]), this species immediately became a prime model for studying GnRHs in primates and humans, who, like zebrafish, possess 2 GnRHs. The fact that the traditional mammalian models (i.e., rodents) have only 1 form of GnRH, and thus are not useful as primate/human models, makes zebrafish an even more desirable surrogate species for the study of the primate GnRH system.

For years, researchers using fish models suffered from the lack of knock-out technologies, a situation that crippled our ability to gain a full understanding of processes and functions compared to mammalian species. This situation persisted until gene editing (TALEN/CRISPR-Cas9) emerged less than a decade ago ([@b0690], [@b0295]), and was quickly implemented in fish studies (reviewed by [@b1005]). Obviously, many fish reproductive biologists began to use this platform as a "loss-of-function" research tool, which eventually will no doubt reveal the exact functions of each of the GnRH forms. However, my team certainly did not expect the shocking result that knocking out GnRH3 in zebrafish, the hypophysiotropic form in this species, had absolutely no effect on reproduction and spawning ([@b0750]). We then thought that perhaps GnRH2 may also be involved in reproductive competence and/or may provide redundancy or some form of compensation for the lack of GnRH3. To our further surprise, fish in which GnRH2 was knocked-out ([@b0420]) or fish with a double knockout of both GnRH2 and GnRH3 ([@b0415]) continued to reproduce normally. Very interestingly, this situation may be different in fish with 3 GnRHs, as knocking out the hypophysiotropic GnRH1 in medaka results in failure of ovulation, however males are still fertile ([@b0800]). Confirming and adding to the zebrafish finding, [@b0400] found that triple knockout zebrafish, with mutations in GnRH3 and Kisspeptin 1 and 2, also displayed normal reproduction.

The lack of distinct reproductive phenotypes in GnRH knockouts led many of us to hypothesize that in the absence of the GnRHs, other factors/hormones may be upregulated and compensate for the lack of GnRHs, sustaining the activity of the HPG axis and ensuring successful reproduction. Several follow-up studies led to a number of theories regarding mechanisms of compensation/redundancy and suggested potential candidates for these roles, which were summarized in multiple recent reviews ([@b0395], [@b0860], [@b0920], [@b0460]). An array of brain factors known to be involved in reproduction, such as GnIH, NKBs, kisspeptins, secretoneurins and others, have been hypothesized to take over the GnRH activities in their absence, through as yet to be discovered redundancy or compensation pathways. A very recent study conducted in a collaboration that I highly enjoy, between the lab of Yoav Gothilf, my former PhD student, and my group, provided convincing data suggesting that Kiss 1 (which is not believed to be involved in fish reproduction) compensates for the absence of Kiss2 (the reproductively relevant Kiss form) in Kiss2 knockout zebrafish ([@b0200], this volume). Interestingly, Vance Trudeau's group provided evidence for the existence of a new neuropeptide, secretoneurin (SN), that can act both independently and along with the GnRHs in regulating pituitary gonadotropin release ([@b0870], [@b0865]). Further studies indicated that SN is also likely involved in regulating the GnRH system ([@b0725]). Vance's group recently demonstrated that targeted mutation of the two secretogranin-2 genes involved in SN synthesis leads to significant reproductive malfunction in zebrafish ([@b0445]), indicating a key role for SN in the endocrine control of fish reproduction.

The gene editing revolution has added mystery and challenges, not only in the study of brain reproductive peptides, but also at lower levels of the HPG axis. Studies by Wei Ge, Christopher H.K. Cheng (Univ. of Hong Kong) and one of our very early colleagues and friend, Hao-Ren Lin, showed that knocking out LH and FSH in zebrafish results in some reproductive abnormalities ([@b0120], [@b0990], [@b1005], [@b0385]), and double knockout of the gonadotropin receptors in the gonads results in infertility ([@b0120], [@b0995], [@b1005], [@b0385]). Taken together with the lack of reproductive effects in the GnRH and kisspeptin knockouts, this suggests that at the level of the brain, there is higher plasticity and functional redundancy of multiple reproductive neuropeptides, whereas downstream in the HPG axis, factors at the pituitary and gonadal level may be more specialized and less disposed to compensation. The implementation of gene editing in the study of GnRHs and, more generally, in fish reproductive biology, is still in its infancy. A broader integration of gene editing in our field will no doubt generate a flurry of exciting discoveries within the next 5-10 years.

5. A few concluding thoughts: {#s0025}
=============================

During my 46 years in basic and translational fish reproductive biology, I have seen the field evolve in parallel to the life sciences revolution and the expansion of its modern platforms. In my concluding remarks at the 2014 10^th^ ISRPF in Faro, Portugal, I analyzed trends in our field from the first ISRPF in 1977 until that point (see also [@b0070]), and I have now added the 2018 11^th^ ISRPF in Brazil to that analysis. As shown in [Figure 5](#f0025){ref-type="fig"} , at the 1977 1^st^ ISRPF, there was no mention of any molecular studies, all presentations were addressing aspects of "physiology". In every ISRPF meeting since then, we have seen an increase in the number of "molecular" studies, and at the 10^th^ and 11^th^ ISRPF ∼80% of the presentations involved molecular aspects. The application of platforms of genomics/functional genomics and other -omics has become dominant. While this molecular revolution has driven the field to greater levels of understanding, the next generations of scientists would be well served to remember that 'simple' animal physiology must remain an indispensable component of our field. Future basic and translational discoveries will require the integration and synergism of physiological and molecular approaches.Figure 5The percent of total presentations at the International Symposia on Reproductive Physiology of Fish (ISRPF) that used physiological (blue) or molecular (red) platforms.

Another very striking trend is in the number of presentations using the zebrafish model ([Figure 6](#f0030){ref-type="fig"} ), which has increased from zero in the years from 1977 up until 1995, to 12% in 2014, and then to 29% in 2018 (more than doubling in four short years). Again, as discussed earlier in this review, while zebrafish and medaka have indeed paved the way to new avenues of tools and research, we should not abandon the larger fish models and/or the species of aquacultural importance.Figure 6The percent of total presentations at the International Symposia on the Reproductive Physiology of Fish (ISRPF) in which the zebrafish model was studied.

Before concluding this review, I would like to say a few words about the unique underlying distinctions that I have observed in our community of fish reproductive physiologists, features that set us apart from other fields. First and foremost - our people. I believe that those of us studying fish reproductive biology have not randomly stumbled into the field. We are here because we have a passion for fish and fish biology, for the oceans, for aquaculture. Therefore, we all share the same enthusiasm, and it shows. Over my many years in the field, I have enjoyed working with my colleagues, and many have become enduring friendships. Hence, the sense of family in our research community is once again a unifying factor that ultimately dictates how we interact, collaborate and work together to collectively advance the field. As I write these concluding lines, we are in the midst of the COVID-19 pandemic. It is heartwarming to see how many of us interact via email, social media, phone and video conferencing to ensure that our scientific friends and colleagues are safe and healthy.

Nowadays, the academic community at large recognizes the utmost importance of multidisciplinary and collaborative research. As indicated by a few examples given in this review, we in the field of fish reproductive biology have understood this from the beginning and developed a culture of collaborative research and integrating expertise. Such cooperation is not always the case in the life sciences and cannot be taken for granted -- but for the ISRPF family, it has always been and should continue to be appreciated and fostered.

And finally, the beneficial "gene flow" in our field is quite obvious. As we all look around (and I have provided a few examples in this review), we can see that many of our 'offspring' (grad students, post-docs) remain in the field, amplify and improve it. These new generations will continue to ensure progress in our field during the next five decades and beyond. When I am asked what I am most proud of in my career, my answer is without a doubt the 'spawning' of many top-notch students and post-docs over the years (e.g. [Figure 7](#f0035){ref-type="fig"} ). I am very proud of them, they have all developed successful careers in the life sciences and have made an impact around the world. Many have remained in fish and reproductive biology, and some have already produced their own ex-students who are now the F3 generation in our community. In humble appreciation of the above, I dedicate this review to all those who I have been fortunate to work with during my 46 highly rewarding years in fish reproductive biology- my students, group members, colleagues and friends.Figure 7Yoni Zohar with members of his team during a (fish) break from the XII International Congress of Comparative Endocrinology in Toronto, Canada (May 1993). From right to left: Shimon Hassin (PhD student); Abigail Elizur (a close collaborator); Yoav Gothilf (PhD student); Constantinos (Dinos) Mylonas (PhD student) ; Claire Holland (PhD student); John Stubblefield (research associate) and Verapong Vuthiphandchai (PhD student).
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